Integrating E-cadherin expression levels with TNM staging for enhanced prognostic prediction in colorectal cancer patients

Abstract Purpose This study aimed to investigate the clinical significance of E-cadherin expression levels in colorectal cancer tissues and explore the relationship between E-cadherin expression and tumor node metastasis (TNM) stage. The goal was to establish a more accurate prognostic prediction fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Jae-Ghi Lee, Ilkyu Park, Hannah Lee, Seungyoon Nam, Jisup Kim, Won-Suk Lee, Myunghee Kang, Jung Ho Kim
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-025-13539-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823861990845579264
author Jae-Ghi Lee
Ilkyu Park
Hannah Lee
Seungyoon Nam
Jisup Kim
Won-Suk Lee
Myunghee Kang
Jung Ho Kim
author_facet Jae-Ghi Lee
Ilkyu Park
Hannah Lee
Seungyoon Nam
Jisup Kim
Won-Suk Lee
Myunghee Kang
Jung Ho Kim
author_sort Jae-Ghi Lee
collection DOAJ
description Abstract Purpose This study aimed to investigate the clinical significance of E-cadherin expression levels in colorectal cancer tissues and explore the relationship between E-cadherin expression and tumor node metastasis (TNM) stage. The goal was to establish a more accurate prognostic prediction for colorectal cancer patients by analyzing E-cadherin expression levels alongside TNM staging. Methods The study examined colorectal cancer patients by dividing them into groups based on E-cadherin expression levels. It then assessed their 5-year event-free survival (EFS) and disease-specific survival (DSS) hazard ratios (HRs). Additionally, the prognosis of patients was analyzed by combining E-cadherin expression levels with TNM staging, particularly focusing on patients in stages III and IV. Results The E-cadherinLow group had significantly worse outcomes, with HRs of 2.30 for EFS and 2.76 for DSS compared to the E-cadherinHigh group. When combined with TNM stage III/IV, patients with E-cadherinLow expression showed a poor prognosis, with HRs of 1.93 for EFS and 2.35 for DSS compared to those with E-cadherinHigh expression at the same TNM stage. Conclusions Low levels of E-cadherin expression are associated with a poor prognosis and decreased survival in colorectal cancer patients. Combining E-cadherin expression levels with TNM staging provides a more precise prediction of patient prognosis and survival, potentially guiding personalized treatment strategies.
format Article
id doaj-art-a165b4faa5a04e309093dc9a95a315af
institution Kabale University
issn 1471-2407
language English
publishDate 2025-01-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj-art-a165b4faa5a04e309093dc9a95a315af2025-02-09T12:41:32ZengBMCBMC Cancer1471-24072025-01-0125111010.1186/s12885-025-13539-9Integrating E-cadherin expression levels with TNM staging for enhanced prognostic prediction in colorectal cancer patientsJae-Ghi Lee0Ilkyu Park1Hannah Lee2Seungyoon Nam3Jisup Kim4Won-Suk Lee5Myunghee Kang6Jung Ho Kim7Gachon Medical Research Institute, Gachon Biomedical Convergence Institute, College of Medicine, Gachon University Gil Medical Center, Gachon UniversityGachon Medical Research Institute, Gachon Biomedical Convergence Institute, College of Medicine, Gachon University Gil Medical Center, Gachon UniversityDepartment of Internal Medicine, College of Medicine, Gachon University Gil Medical Center, Gachon UniversityAI Convergence Center for Medical Science, Department of Genome Medicine and Science, Gachon University Gil Medical Center, Gachon University College of MedicineDepartment of Pathology, College of Medicine, Gachon University Gil Medical Center, Gachon UniversityDepartment of Surgery, College of Medicine, Gachon University Gil Medical Center, Gachon UniversityDepartment of Pathology, Dongkang Medical CenterGachon Medical Research Institute, Gachon Biomedical Convergence Institute, College of Medicine, Gachon University Gil Medical Center, Gachon UniversityAbstract Purpose This study aimed to investigate the clinical significance of E-cadherin expression levels in colorectal cancer tissues and explore the relationship between E-cadherin expression and tumor node metastasis (TNM) stage. The goal was to establish a more accurate prognostic prediction for colorectal cancer patients by analyzing E-cadherin expression levels alongside TNM staging. Methods The study examined colorectal cancer patients by dividing them into groups based on E-cadherin expression levels. It then assessed their 5-year event-free survival (EFS) and disease-specific survival (DSS) hazard ratios (HRs). Additionally, the prognosis of patients was analyzed by combining E-cadherin expression levels with TNM staging, particularly focusing on patients in stages III and IV. Results The E-cadherinLow group had significantly worse outcomes, with HRs of 2.30 for EFS and 2.76 for DSS compared to the E-cadherinHigh group. When combined with TNM stage III/IV, patients with E-cadherinLow expression showed a poor prognosis, with HRs of 1.93 for EFS and 2.35 for DSS compared to those with E-cadherinHigh expression at the same TNM stage. Conclusions Low levels of E-cadherin expression are associated with a poor prognosis and decreased survival in colorectal cancer patients. Combining E-cadherin expression levels with TNM staging provides a more precise prediction of patient prognosis and survival, potentially guiding personalized treatment strategies.https://doi.org/10.1186/s12885-025-13539-9Colorectal cancerE-cadherinPrognosisTNM staging
spellingShingle Jae-Ghi Lee
Ilkyu Park
Hannah Lee
Seungyoon Nam
Jisup Kim
Won-Suk Lee
Myunghee Kang
Jung Ho Kim
Integrating E-cadherin expression levels with TNM staging for enhanced prognostic prediction in colorectal cancer patients
BMC Cancer
Colorectal cancer
E-cadherin
Prognosis
TNM staging
title Integrating E-cadherin expression levels with TNM staging for enhanced prognostic prediction in colorectal cancer patients
title_full Integrating E-cadherin expression levels with TNM staging for enhanced prognostic prediction in colorectal cancer patients
title_fullStr Integrating E-cadherin expression levels with TNM staging for enhanced prognostic prediction in colorectal cancer patients
title_full_unstemmed Integrating E-cadherin expression levels with TNM staging for enhanced prognostic prediction in colorectal cancer patients
title_short Integrating E-cadherin expression levels with TNM staging for enhanced prognostic prediction in colorectal cancer patients
title_sort integrating e cadherin expression levels with tnm staging for enhanced prognostic prediction in colorectal cancer patients
topic Colorectal cancer
E-cadherin
Prognosis
TNM staging
url https://doi.org/10.1186/s12885-025-13539-9
work_keys_str_mv AT jaeghilee integratingecadherinexpressionlevelswithtnmstagingforenhancedprognosticpredictionincolorectalcancerpatients
AT ilkyupark integratingecadherinexpressionlevelswithtnmstagingforenhancedprognosticpredictionincolorectalcancerpatients
AT hannahlee integratingecadherinexpressionlevelswithtnmstagingforenhancedprognosticpredictionincolorectalcancerpatients
AT seungyoonnam integratingecadherinexpressionlevelswithtnmstagingforenhancedprognosticpredictionincolorectalcancerpatients
AT jisupkim integratingecadherinexpressionlevelswithtnmstagingforenhancedprognosticpredictionincolorectalcancerpatients
AT wonsuklee integratingecadherinexpressionlevelswithtnmstagingforenhancedprognosticpredictionincolorectalcancerpatients
AT myungheekang integratingecadherinexpressionlevelswithtnmstagingforenhancedprognosticpredictionincolorectalcancerpatients
AT junghokim integratingecadherinexpressionlevelswithtnmstagingforenhancedprognosticpredictionincolorectalcancerpatients